TERBASMIN EXPECTORANTE SOLUCION
|
|
- Lesley Stafford
- 5 years ago
- Views:
Transcription
1 TERBASMIN EXPECTORANTE SOLUCION Read the whole of this prospectus in detail, because it contains information that will be important to you. This medication can be obtained without a prescription for the treatment of minor afflictions without the intervention of a doctor. However, you must use Terbasmin Expectorante solución with care to obtain the best results. -Keep this prospectus; you may need to read it again. -If you have any doubts, consult your doctor or pharmacists. This medicine has been prescribed to you and must not be given to others. It may harm them, even when their symptoms are the same as yours. In this prospectus: 1. What are Terbasmin Expectorante solución and what are they used for? 2. Before using Terbasmin Expectorante solución 3. How to use Terbasmin Expectorante solución 4. Possible side effects 5. Conservation of Terbasmin Expectorante solución Each dosed measure of 5ml contains 1.5mg of terbutaline sulphate and 66.6mg of guaifenesin. The other components (excipients) are: sorbitol (E420), glycerol (E422), citric acid, sodium hydroxide, sodium benzoate (E211), disodium edentate, sodium saccharin, menthol, aroma of raspberry, aroma of lemon-limette and purified water. 1. WHAT IS TERBASMIN EXPECTORANTE SOLUCION AND WHAT IS IT USED FOR? TERBASMIN EXPECTORANTE SOLUCION is an oral solution. It is presented in a 180ml solution container. TERBASMIN EXPECTORANTE SOLUCION is a systematic stimulant which dilates the respiratory paths facilitating breathing. TERBASMIN EXPECTORANTE SOLUCION proportions rapid relief of symptoms like breathing difficulty in patients with asthma or similar conditions. In the same way, TERBASMIN EXPECTORANTE SOLUCION fluidifies mucous, which allows the alleviation of a cough. TERBASMIN EXPECTORANTS SOLUCION will be employed regularly in order to prevent breathing problems expected in these types of conditions. TERBASMIN EXPECTORANTE SOLUCION does not alleviate an acute asthma attack when it has already started. 2. BEFORE TAKING TERBASMIN EXPECTORANTE SOLUCION Do not take TERBASMIN EXPECTORANTE SOLUCION: - If you are allergic to terbutaline or other components of this product. Be especially careful with TERBASMIN EXPECTORANTE: - If you have previously shown any unusual reaction to Terbasmin (terbutaline)or other medicines you must communicate this to your doctor.
2 - If you suffer from other conditions, especially if these are cardiac problems, diabetes or thyroid disorders (hyperthyroidism), you must communicate this to your doctor. Pregnancy: Consult your doctor or pharmacist before taking any medication. IMPORTANT FOR WOMEN If you are pregnant or think you may be, consult your doctor before taking this medication. The consumption of medicines during pregnancy may be dangerous for the embryo or fœtus and must be monitored by your doctor. Prejudicial effects during pregnancy have not been observed. Even so, tell your doctor as soon as possible if you become pregnant while being treated with Terbasmin. Breast feeding Consult your doctor or pharmacist before taking any medication. Prejudicial effects when breast feeding have not been observed. Sportspeople We inform sportspeople that this medicine contains a component that can establish positive results in analytic drug tests. Driving and using machines TERBASMIN EXPECTORANTE SOLUCION at recommended doses has not had any reported effects on driving capacity or the ability to use machines. Important information about some of the components of TERBASMIN EXPECTORANTE SOLUCION: As this medicine contains glycerol as an excipient it can be prejudicial at large doses. It can provoke headaches, stomach discomfort and diarrhoea. As it contains sodium benzoate as an excipient it can slightly irritate the eyes, skin and mucosa. It can increase the risk of yellow colouring of the skin (jaundice) in newborns. This medicine contains 1.25g of sorbitol as an excipient for each dosed measure of 5ml. It can cause stomach discomfort and diarrhoea. It must not be used with patients with a hereditary intolerance to fructose. Taking other medication Inform your doctor or pharmacist if you are taking or have recently taken any other medicine even those acquired without prescription. Bear in mind that these instructions may be applicable to medicines taken before or afterwards. Certain medicines for the treatment of hypertension, heart conditions and some antibiotics, the beta blockers, can reduce or cancel the effect of Terbasmin when administered in conjunction. It is also possible to observe low levels of potassium in the blood when Terbasmin is used with other medicines. Normally this effect is not important, but in some cases it can influence the cardiac rhythm.
3 3. HOW TO USE TERBASMIN EXPECTORANTE SOLUCION Follow these instructions unless your doctor has given you distinct indications. Remember to take your medicine. Your doctor will indicate the length of treatment with TERBASMIN EXPECTORANTE SOLUCION. Do not suspend the treatment without first consulting your doctor. If you feel that the effect of TERBASMIN EXPECTORANTE SOLUCION is too strong or weak communicate this to your doctor or pharmacist. TERBASMIN EXPECTORANTE SOLUCION is administered orally. Administration: Habitual dose for adults: 3-4.5mg (10-15ml) 3 times in 24 hours. Habitual dose for children: The dose will depend on the child s body weight as indicated on the following table: Recommended doses: Body weight (kg) Dosage Body weight (kg) Dosage 4 1ml x ml x ml x ml x 3 8 2ml x ml x ml x ml x ml x ml x ml x ml x ml x ml x 3 If you take more TERBASMIN EXPECTORANTE SOLUCION than you should, immediately consult your doctor or pharmacist. The most common symptoms and signs which can be produced after an overdose are: nausea, headaches, fast or irregular cardiac rhythm, muscular cramps, nervousness, uneasiness, trembling, fainting or unusual drowsiness. In the case of accidental overdose, consult the Toxicology Information Service, Telephone , indicating the product and amount administered. If you forgot to take TERBASMIN EXPECTORANTE SOLUCION Do not take a double dose to compensate the treatment with TERBASMIN EXPECTORANTE SOLUCION. In the case of forgetting a dose, take one as soon as you remember. However, if the next dose is very soon, wait till then. 4. POSSIBLE SIDE EFFECTS As with all medicines TERBASMIN EXPECTORANTE SOLUCION can produce side effects. If side effects are produced, these are weak and disappear after one or two weeks treatment. Even so, communicate the following side effects which cause discomfort or do not disappear to your doctor: Frequent side effects: Trembling Rapid cardiac rhythm
4 Infrequent side effects: Nausea Skin rashes Serious headaches Muscular cramps Difficulty sleeping and mood changes have been observed Rare side effects Irregular heartbeats have been registered If you observe any other side effect not mentioned in this information pamphlet, consult your doctor or pharmacist. 5. CONSERVATION OF TERBASMIN EXPECTORANTE SOLUCION Maintain TERBASMIN EXPECTORANTE SOLUCION out of reach and sight of children. It does not need special conditions for conservation. Expiry: Do not use TERBASMIN EXPECTORANTE SOLUCION after the expiry date indicated on the container. Medicines must not be disposed of in the drains or thrown away. Leave unwanted medicines and containers at the SIGRE point in a chemist. Ask your pharmacist how to dispose of any containers or unneeded medicines. This way you will help look after the environment. Holder of the authorisation for the commercialisation and fabrication of the product. LABORATORIOS ERN, S.A. Pedro IV, Barcelona, España Responsable for fabrication. LABORATORIOS ERN, S.A. Pedro IV, Barcelona, España Laboratorios ERN, S.A. Gorcs i LLadó, Barberá del Vallés, Barcelona. España. This information pamphlet was approved in June Detailed and updated information about this product is available on the webpage of the Spanish Agency for Medicines and Health Products (AEMPS)
5
USER INFORMATION PAMPHLET SENIORAL jarabe niños Clocinizine dihydrochloride/phenylpropanolamine hydrochloride
USER INFORMATION PAMPHLET SENIORAL jarabe niños Clocinizine dihydrochloride/phenylpropanolamine hydrochloride Read the whole of this prospectus in detail, because it contains information that will be important
More informationUser Information Pamphlet Paracetamol Level 100 mg/ml oral solution EFG
User Information Pamphlet Paracetamol Level 100 mg/ml oral solution EFG Read the whole of this prospectus in detail, because it contains information that will be important to you. This medication can be
More informationUSER INFORMATION PAMPHLET. Metalgial 500mg/ml oral drops in solution (sodium metamizole)
USER INFORMATION PAMPHLET Metalgial 500mg/ml oral drops in solution (sodium metamizole) Read the whole of this prospectus in detail, because it contains information that will be important to you. This
More informationUser Information Pamphlet Apiretal 325/500mg Comprimidos Bucodispersables (Paracetamol)
User Information Pamphlet Apiretal 325/500mg Comprimidos Bucodispersables (Paracetamol) Read the whole of this prospectus in detail, because it contains information that will be important to you. This
More informationProspectus: User information Astenolit solución oral
Prospectus: User information Astenolit solución oral Read the whole of this prospectus in detail, because it contains information that will be important to you. This medication can be obtained without
More informationUSER INFORMATION PAMPHLET Suero Fisiológico Vitulia 0.9% solution for perfusion Sodium chloride
USER INFORMATION PAMPHLET Suero Fisiológico Vitulia 0.9% solution for perfusion Sodium chloride Read the whole of this prospectus in detail, because it contains information that will be important to you.
More informationPAMPHLET : INFORMATION FOR THE USER Adrenaline Level 1mg/ml injectable solution Eponefrina
PAMPHLET : INFORMATION FOR THE USER Adrenaline Level 1mg/ml injectable solution Eponefrina Please read the whole information pamphlet carefully before starting to use this medicine. - Do not throw this
More informationPackage leaflet: Information for the user. Bricanyl Respules 2.5 mg/ml Nebuliser Solution terbutaline sulfate
Package leaflet: Information for the user Bricanyl Respules 2.5 mg/ml Nebuliser Solution terbutaline sulfate Read all of this leaflet carefully before you start using this medicine because it contains
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Bricanyl Turbohaler 0.5 mg/dose terbutaline sulphate
PACKAGE LEAFLET: INFORMATION FOR THE USER Bricanyl Turbohaler 0.5 mg/dose terbutaline sulphate Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need
More informationPackage leaflet: Information for the patient. / / 30 mg/5 ml syrup. Ambroxol hydrochloride
Package leaflet: Information for the patient / / 30 mg/5 ml syrup Ambroxol hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationImodium 1 mg/5 ml oral solution
PACKAGE LEAFLET: INFORMATION FOR THE USER Imodium 1 mg/5 ml oral solution Loperamide hydrochloride Imodium is a registered trademark Read all of this leaflet carefully before you start using this medicine
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate)
PACKAGE LEAFLET: INFORMATION FOR THE USER ZADITEN 1 mg/5 ml Oral Solution Ketotifen (as Ketotifen hydrogen fumarate) Read all of this leaflet carefully because it contains important information for you.
More informationPackage leaflet: Information for the user. Bricanyl Turbohaler 0.5 mg/dose terbutaline sulfate
Package leaflet: Information for the user Bricanyl Turbohaler 0.5 mg/dose terbutaline sulfate Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER
PACKAGE LEAFLET: INFORMATION FOR THE USER Fucidin 250 mg/5 ml Oral Suspension fusidic acid Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPATIENT INFORMATION LEAFLET. Active substances: Each 5 ml syrup (1 spoon) contains 2.5 mg desloratadine.
ALORES 2.5mg/5ml syrup For oral use only. PATIENT INFORMATION LEAFLET Active substances: Each 5 ml syrup (1 spoon) contains 2.5 mg desloratadine. Excipients: Propylene glycol, sorbitol 70% (E420), citric
More informationPackage leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine
Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Always
More informationBenylin Phlegm Cough Menthol 100mg/5ml Oral Solution Guaifenesin
Benylin Phlegm Cough Menthol 100mg/5ml Oral Solution Guaifenesin Read all of this leaflet carefully before you start using this medicine because it contains important information for you. Always use this
More informationPackage Leaflet: INFORMATION FOR THE USER. PARACODIN 10 mg/g oral drops, solution (dihydrocodeine hydrorhodanide)
Package Leaflet: INFORMATION FOR THE USER PARACODIN 10 mg/g oral drops, solution (dihydrocodeine hydrorhodanide) Read all of this leaflet carefully before you start taking this medicine because it contains
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam)
PACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam) Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read
More informationMEDICATION GUIDE Morphine Sulfate (MOR feen SUL fate) (CII) Oral Solution
MEDICATION GUIDE Morphine Sulfate (MOR feen SUL fate) (CII) Oral Solution IMPORTANT: Keep morphine sulfate oral solution in a safe place away from children. Accidental use by a child is a medical emergency
More informationPackage leaflet: Information for the user. Therimin Skogsbär 500 mg Powder for Oral Solution Paracetamol
Package leaflet: Information for the user Therimin Skogsbär 500 mg Powder for Oral Solution Paracetamol Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationMEDICATION GUIDE Morphine Sulfate (mor-pheen) (CII) Oral Solution
MEDICATION GUIDE Morphine Sulfate (mor-pheen) (CII) Oral Solution IMPORTANT: Keep Morphine Sulfate Oral Solution in a safe place away from children. Accidental use by a child is a medical emergency and
More informationOXEZE TURBUHALER formoterol fumarate dihydrate dry powder for oral inhalation
IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION OEZE TURBUHALER formoterol fumarate dihydrate dry powder for oral inhalation This leaflet is part III of a three-part Product Monograph published when
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER
PACKAGE LEAFLET: INFORMATION FOR THE USER ARICEPT Evess 5 mg Orodispersible Tablets ARICEPT Evess 10 mg Orodispersible Tablets (Donepezil Hydrochloride) You and your caregiver should read all of this leaflet
More informationPHENYLEPHRINE. Please read this leaflet and the label of the medicine you purchased, carefully before you start using Phenylephrine.
What is in this leaflet PHENYLEPHRINE New Zealand Consumer Medicine Information The medicine you have purchased contains Phenylephrine. This leaflet is intended to provide information on the active ingredient
More informationVentolin Injection 500 micrograms/ml salbutamol sulfate
Package leaflet: Information for the user Ventolin Injection 500 micrograms/ml salbutamol sulfate Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPackage leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime
Package leaflet: Information for the user Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. BritLofex Tablets 0.2mg LOFEXIDINE HYDROCHLORIDE
PACKAGE LEAFLET: INFORMATION FOR THE USER BritLofex Tablets 0.2mg LOFEXIDINE HYDROCHLORIDE Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You may need to
More information1. WHAT OXCARBAZEPINE IS AND WHAT IT IS USED FOR
PACKAGE LEAFLET: INFORMATION FOR THE USER Oxcarbazepine 150/300/600 mg Film-Coated Tablets (Oxcarbazepine) Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You
More informationPATIENT INFORMATION LEAFLET AMLOC RANGE
SCHEDULING STATUS: S3 PROPRIETARY NAME AND DOSAGE FORM: AMLOC 5 mg tablets AMLOC 10 mg tablet Read all of this leaflet carefully before you start taking AMLOC. Keep this leaflet. You may need to read it
More informationFLUIMUKAN PLUS 600 mg effervescent tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER FLUIMUKAN PLUS 600 mg effervescent tablets Acetylcysteine This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for
More informationPACKAGE LEAFLET: INFORMATION FOR THE PATIENT
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT Kopen Sugar Free 125mg/5ml and 250mg/5ml Powder for Oral Solution Phenoxymethylpenicillin Read all of this leaflet carefully before you start taking this medicine
More informationPackage leaflet: Information for the user. Lidocaine Hydrochloride 1% w/v Solution for Injection Lidocaine Hydrochloride
Package leaflet: Information for the user Lidocaine Hydrochloride 1% w/v Solution for Injection Lidocaine Hydrochloride Read all of this leaflet carefully before you start using this medicine because it
More information1. WHAT NICOTINELL SPEARMINT CHEWING-GUM IS AND WHAT IT IS USED FOR
PACKAGE LEAFLET: INFORMATION FOR THE USER Nicotinell Spearmint 2 mg and 4 mg medicated chewing-gum Nicotine Read all of this leaflet carefully because it contains important information for you. This medicine
More informationPackage leaflet: Information for the user. Omnilax 10 g powder for oral solution, sachet. Macrogol 4000
Package leaflet: Information for the user Omnilax 10 g powder for oral solution, sachet Macrogol 4000 Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Irbea 75 mg film-coated tablets Irbesartan
PACKAGE LEAFLET: INFORMATION FOR THE USER Irbea 75 mg film-coated tablets Irbesartan Read all of this leaflet carefully before you start taking this medicine because it contains important information for
More informationPackage leaflet: Information for the user. Nicotinell Tropisk frukt 4 mg medicated chewing-gum
Package leaflet: Information for the user Nicotinell Tropisk frukt 2 mg medicated chewing-gum Nicotinell Tropisk frukt 4 mg medicated chewing-gum nicotine Read all of this leaflet carefully before you
More informationMEDICATION GUIDE Oxycodone Hydrochloride (ox-ee-co-dohn) (CII) Oral Solution, USP
MEDICATION GUIDE Oxycodone Hydrochloride (ox-ee-co-dohn) (CII) Oral Solution, USP IMPORTANT: Keep oxycodone hydrochloride oral solution in a safe place away from children. Accidental use by a child is
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Histabentine 8 mg/16 mg tablets. Betahistine dihydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER Histabentine 8 mg/16 mg tablets Betahistine dihydrochloride Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER
PACKAGE LEAFLET 1 PACKAGE LEAFLET: INFORMATION FOR THE USER Vasexten 10, 10 mg modified release capsules Vasexten 20, 20 mg modified release capsules barnidipine hydrochloride Read all of this leaflet
More informationPackage leaflet: Information for the user. Flutamid Stada 250 mg tablets Flutamide
Package leaflet: Information for the user Flutamid Stada 250 mg tablets Flutamide Read all of this leaflet carefully before you start taking this medicine because it contains important information for
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate)
PACKAGE LEAFLET: INFORMATION FOR THE USER DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate) Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need
More informationPATIENT INFORMATION LEAFLET FOR TEXA 10 mg TABLETS AND TEXA SYRUP PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM:
SCHEDULING STATUS: S2 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: TEXA 10 mg (tablets) TEXA SYRUP (syrup) Read this entire leaflet carefully before you start taking TEXA. Keep this leaflet. You
More informationChemists Own Strong Pain Extra Paracetamol and Codeine Phosphate
Chemists Own Strong Pain Extra Paracetamol and Codeine Phosphate Consumer Medicine Information(CMI) Please read this information before you start taking this medicine. What is in this CMI? This CMI answers
More informationPackage leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)
Package leaflet: Information for the patient Bumetanide 1 mg and 5 mg Tablets (bumetanide) Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationDo not use Easyhaler Salbutamol if you are allergic (hypersensitive) to: Salbutamol lactose
Package leaflet: Information for the patient user Easyhaler Salbutamol Sulphate 100 and 200 micrograms/dose inhalation powder Salbutamol sulphate (salbutamol) Read all of this leaflet carefully before
More informationConsumer Medicine Information TOPICIL. Please read this leaflet carefully before you start using Topicil Capsules.
Clindamycin hydrochloride Capsules 150 mg What is in this leaflet Consumer Medicine Information TOPICIL Please read this leaflet carefully before you start using Topicil Capsules. This leaflet answers
More informationPackage leaflet: Information for the user. Famvir 125, 250 and 500 mg film-coated tablets famciclovir
Package leaflet: Information for the user Famvir 125, 250 and 500 mg film-coated tablets famciclovir Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationLYSOBACT COMPLETE SPRAY ( ) mg / ml Oromucosal spray, solution
PACKAGE LEAFLET: INFORMATION FOR THE USER LYSOBACT COMPLETE SPRAY (20 + 1.5 + 0.5) mg / ml Oromucosal spray, solution LYSOZYME, CETYLPYRIDINIUM, LIDOCAINE This leaflet is a copy of the Summary of Product
More informationPackage leaflet: Information for the user
Package leaflet: Information for the user Emerade 150 micrograms solution for injection in pre-filled pen Emerade 300 micrograms solution for injection in pre-filled pen Emerade 500 micrograms solution
More informationเอกสารกาก บยาภาษาอ งกฤษ. AVAXIM 160 U Suspension for injection in a prefilled syringe Hepatitis A vaccine (inactivated, adsorbed)
เอกสารกาก บยาภาษาอ งกฤษ AVAXIM 160 U Suspension for injection in a prefilled syringe Hepatitis A vaccine (inactivated, adsorbed) Read all of this leaflet carefully before youstart using this medicine because
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin
PACKAGE LEAFLET: INFORMATION FOR THE USER XIFAXANTA 200 mg film-coated tablets Rifaximin Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationDuro-Tuss Dry Cough Liquid plus Nasal Decongestant Pholcodine (fol-co-dean); Pseudoephedrine hydrochloride (sue-doe-eff-eh-drine hydro-klor-ide)
Duro-Tuss Dry Cough Liquid plus Nasal Decongestant Pholcodine (fol-co-dean); Pseudoephedrine hydrochloride (sue-doe-eff-eh-drine hydro-klor-ide) Consumer Medicine Information What is in this leaflet This
More informationPATIENT INFORMATION LEAFLET PEARINDA PLUS
SCHEDULING STATUS OF THE MEDICINAL PRODUCT S3 NAME OF MEDICINAL PRODUCT 2 (Tablet) 4 (Tablet) Read this leaflet carefully before you start taking. Keep this leaflet. You may need to read it again. If you
More informationPATIENT INFORMATION LEAFLET
PATIENT INFORMATION LEAFLET Page 1 of 6 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Artefan 20/120 * artemether/lumefantrine 20mg/120mg tablets Read all of this leaflet carefully before you start
More informationWhat is the most important information I should know about Morphine Sulfate Oral Solution?
Medication Guide MORPHINE SULFATE (mor-pheen) (CII) Oral Solution IMPORTANT: Keep Morphine Sulfate Oral Solution in a safe place away from children. Accidental use by a child is a medical emergency and
More informationPATIENT INFORMATION LEAFLET DYNARB RANGE
SCHEDULING STATUS: S3 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: DYNARB 75 mg tablets DYNARB 150 mg tablets DYNARB 300 mg tablets Read all of this leaflet carefully before you start taking DYNARB.
More informationPHOLCODINE. Please follow the instructions on the packaging of the medicine you purchased and in this leaflet before you start using pholcodine.
PHOLCODINE New Zealand Consumer Medicine Information What is in this leaflet The medicine you have purchased contains pholcodine. This leaflet is intended to provide information on the active ingredient
More informationPATIENT INFORMATION LEAFLET POLLENTYME S AND TABS
SCHEDULING STATUS: S1 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: POLLENTYME TABLETS (tablets) POLLENTYME S (syrup) Read all of this leaflet carefully because it contains important information
More informationIndopril perindopril. Consumer Medicine Information (CMI) What is in this leaflet. What INDOPRIL is used for
Indopril perindopril Consumer Medicine Information (CMI) What is in this leaflet This leaflet answers some common questions about. It does not contain all the available information. It does not take the
More informationPackage leaflet: Information for the user. Fluvastatin
Package leaflet: Information for the user Lescol XL 80 mg prolonged-release tablets Fluvastatin Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationNORVASC 5 mg and 10 mg tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER NORVASC 5 mg and 10 mg tablets AMLODIPINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which
More informationPackage Leaflet: Information for the User. Clonamox 125 mg/5 ml Powder for Oral Suspension Clonamox 250 mg/5 ml Powder for Oral Suspension
Package Leaflet: Information for the User Clonamox 125 mg/5 ml Powder for Oral Suspension Clonamox 250 mg/5 ml Powder for Oral Suspension Amoxicillin Read all of this leaflet carefully before you start
More informationPackage leaflet: Information for the user. Ondansetron 4mg/5ml Syrup (ondansetron as ondansetron hydrochloride dihydrate)
Package leaflet: Information for the user Ondansetron 4mg/5ml Syrup (ondansetron as ondansetron hydrochloride dihydrate) Read all of this leaflet carefully before you start taking this medicine because
More informationVentolin Accuhaler 200 micrograms salbutamol sulfate
Package Leaflet: Information for the User Ventolin Accuhaler 200 micrograms salbutamol sulfate Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Paracodin 0.20% w/w Syrup (dihydrocodeine hydrogen tartrate)
PACKAGE LEAFLET: INFORMATION FOR THE USER Paracodin 0.20% w/w Syrup (dihydrocodeine hydrogen tartrate) Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationDulcolax 5 mg, film-coated tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER Dulcolax 5 mg, film-coated tablets BISACODYL This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which
More informationPackage leaflet: Information for the user. Nicovel Frukt 4 mg medicated chewing-gum. nicotine
Package leaflet: Information for the user Nicovel Frukt 2 mg medicated chewing-gum Nicovel Frukt 4 mg medicated chewing-gum nicotine Read all of this leaflet carefully before you start using this medicine
More informationMEDICATION GUIDE MORPHINE Sulfate Oral Solution (mor-pheen) CII Rx only
MEDICATION GUIDE MORPHINE Sulfate Oral Solution (mor-pheen) CII Rx only IMPORTANT: Keep Morphine Sulfate Oral Solution in a safe place away from children. Accidental use by a child is a medical emergency
More informationBenylin Children's Coughs & Colds 5mg/0.625mg per 5ml Syrup dextromethorphan, triprolidine
Benylin Children's Coughs & Colds 5mg/0.625mg per 5ml Syrup dextromethorphan, triprolidine This medicine is used to help relieve children s dry cough and cold symptoms. This medicine is for use by children
More informationPackage leaflet: Information for the user
Package leaflet: Information for the user Benylin Dry Coughs Syrup Diphenhydramine hydrochloride 14 mg/5ml Dextromethorphan hydrobromide 6.5 mg/5ml Levomenthol 2 mg/5ml Read all of this leaflet carefully
More informationBenylin Phlegm Cough plus Decongestant Syrup
Package leaflet: Information for the user Benylin Phlegm Cough plus Decongestant Syrup Guaifenesin 100mg/5ml Pseudoephedrine Hydrochloride 30mg/5ml. Read all of this leaflet carefully before you start
More informationPATIENT INFORMATION LEAFLET
PPM Code: E1981 PATIENT INFORMATION LEAFLET SCHEDULING STATUS: S2 PROPRIETARY NAME DOSAGE FORM: film coated tablets Read all of this leaflet carefully because it contains important information for you.
More informationPATIENT INFORMATION LEAFLET BILOCOR RANGE
SCHEDULING STATUS: S3 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM BILOCOR 5 tablets BILOCOR 10 tablets Please read this leaflet carefully before using BILOCOR 5 / 10 mg tablets Keep this leaflet.
More informationPATIENT INFORMATION LEAFLET
ALORES 2.5mg/5ml Syrup For oral use. PATIENT INFORMATION LEAFLET Active substance(s): Each 5 ml syrup (1 spoon) contains desloratadine 2.5 mg. Excipient(s): Propylene glycol, sorbitol 70%, citric acid
More informationPackage leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)
Package leaflet: Information for the patient Loratadine 10 mg Tablets (loratadine) Read all of this leaflet carefully before you start taking this medicine because it contains important information for
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES. Lubiprostone
PACKAGE LEAFLET PACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES Lubiprostone This medicine is subject to additional monitoring. This will allow quick identification of new
More informationPackage leaflet: Information for the user. Morfin Abcur 10 mg/ml, solution for injection. morphine hydrochloride
Package leaflet: Information for the user Morfin Abcur 10 mg/ml, solution for injection morphine hydrochloride Read all of this leaflet carefully before you start using this medicine because it contains
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT WICK Chesty Cough Syrup 200 mg/15 ml 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 15 ml syrup contains 200 mg guaifenesin. Each ml syrup
More informationIrbenida H 150mg/12,5mg film-coated tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER Irbenida H 150mg/12,5mg film-coated tablets IRBESARTAN/HYDROCHLOROTHIAZIDE This leaflet is a copy of the Summary of Product Characteristics and Patient Information
More informationIMPORTANT: PLEASE READ
PART III: CONSUMER INFORMATION Pr BACLOFEN Baclofen Tablets 10 mg and 20 mg This leaflet is part III of a three-part "Product Monograph" published when BACLOFEN was approved for sale in Canada and is designed
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER SALAGEN 5 mg film-coated tablets Pilocarpine hydrochloride Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may
More informationOXIS TURBUHALER Formoterol fumarate dihydrate for inhalation
OXIS TURBUHALER Formoterol fumarate dihydrate for inhalation Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Oxis Turbuhaler. It does not contain
More informationPackage leaflet: Information for the user. Zantac Syrup ranitidine hydrochloride
Package leaflet: Information for the user Zantac Syrup ranitidine hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
More informationMEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Tablets (CIII)
MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Tablets (CIII) IMPORTANT: Keep SUBOXONE in a secure place away from children. Accidental use by a child is a medical emergency
More information1. What Solpadol is and what it is used for
PATIENT INFORMATION LEAFLET SOLPADOL 30mg/500mg CAPLETS Codeine Phosphate and Paracetamol Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read
More informationRead all of this leaflet carefully before you start taking this medicine.
Moxelle 20mg Tablets Tamoxifen Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor
More informationLochol XL 80 mg Prolonged-release Tablets
Package leaflet: Information for the user Lochol XL 80 mg Prolonged-release Tablets Fluvastatin Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationShare the important information in this Medication Guide with members of your household.
Medication Guide BUPRENORPHINE (BUE-pre-NOR-feen) and NALOXONE (nal-ox-one) Sublingual Tablets, CIII IMPORTANT: Keep buprenorphine and naloxone sublingual tablets in a secure place away from children.
More informationPackage leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000
Package leaflet: Information for the user 10 g powder for oral solution in sachet Macrogol 4000
More informationSANDOMIGRAN. 0.5mg tablet Pizotifen malate
SANDOMIGRAN 0.5mg tablet Pizotifen malate What is in this leaflet This leaflet answers some common questions about Sandomigran. It does not contain all the available information. It does not take the place
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Aspecton Cough Syrup. Thyme soft extract. For adults and children aged 1 year and older
PACKAGE LEAFLET: INFORMATION FOR THE USER Aspecton Cough Syrup Thyme soft extract For adults and children aged 1 year and older Read all of this leaflet carefully before you start taking this medicine
More informationPackage leaflet: Information for the patient. NEGABAN 1g, powder for solution for injection or infusion Temocillin
Package leaflet: Information for the patient NEGABAN 1g, powder for solution for injection or infusion Temocillin Read all of this leaflet carefully before you start using this medicine because it contains
More informationPROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: Read this entire leaflet carefully before you start taking DYNAFLOC.
SCHEDULING STATUS: S4 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: DYNAFLOC 250 (tablets) DYNAFLOC 500 (tablets) DYNAFLOC 750 (tablets) Read this entire leaflet carefully before you start taking
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol)
PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol) Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You may
More informationRead all of this leaflet carefully before you start taking this medicine.
Package Leaflet: Information for the User Tamoxifen 10mg Tablets Tamoxifen Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read it again. If
More informationPatient Information Leaflet
Patient Information Leaflet Ibuprofen 5% w/w Gel Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again. If you have any further questions
More informationMotens 2 mg and 4 mg Tablets lacidipine
Package leaflet: Information for the user Motens 2 mg and 4 mg Tablets lacidipine Read all of this leaflet carefully before you start taking this medicine because it contains important information for
More information